Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    EXT2
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: Comparator: Placebo
2 Completed An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low Dose;   Drug: ALKS 9072, High Dose
3 Terminated
Has Results
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
Conditions: Lung Diseases;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: MK-0873 2.5 mg;   Drug: MK-0873 1.25 mg;   Drug: MK-0873 0.75 mg;   Drug: Placebo to MK-0873;   Drug: Usual Care

Study has passed its completion date and status has not been verified in more than two years.